NCT00728988
Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome
See it on ClinicalTrials.gov ↗499 people
31.7%
68.3%
158 womenmiddle line = equal numbers341 men
- Phase
- PHASE4
- Paid for by
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Finished
- 2010-04
- Health conditions
- Acute Coronary Syndrome
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- Not reported
- Age 65+
- 35.5%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“ST elevated acute myocardial infarction; previously or currently treated with atorvastatin or other statins”
Study titles and rules are shown in their original English.